A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine
Article
[키워드] acute respiratory syndrome
analysed
antibody
antibody titres
BALB/c
BALB/c mouse
boost
CD4
CD8
cellular
cellular immunity
coronavirus
coronavirus disease
COVID-19
COVID-19 vaccine
Delta/B.1.617.2 variant of concern
effective
eight
elicited
emerging and re-Emerging coronaviruses
glycoprotein
homologous
humoral
Humoral immunity
immunization
Japanese
LC16m8
less
mice
motif
multifunctional
neutralized
Neutralizing activity
patients with COVID-19
polybasic
prime-boost immunization.
provide
recombinant
replication-competent viral
S-specific antibody
S1/S2 cleavage site
SARS-CoV-2
serum sample
significantly lower
Strains
T-cell immune responses
T-cell immunity
T-cell Response
the S protein
Vaccine
Vaccine development
vaccine platform
variant
vector
viral vectors
virus
Wuhan
[DOI] 10.1080/22221751.2022.2122580 PMC 바로가기
[DOI] 10.1080/22221751.2022.2122580 PMC 바로가기